Assessment of time from cytoreductive nephrectomy (CN) to initiation of targeted therapy (TT) in patients with metastatic renal cell carcinoma (mRCC).
Winston Vuong
No relevant relationships to disclose
Mark Chang
No relevant relationships to disclose
Nora Ruel
No relevant relationships to disclose
Joann Hsu
No relevant relationships to disclose
Courtney Carmichael
No relevant relationships to disclose
Robert A. Figlin
No relevant relationships to disclose
Sumanta Kumar Pal
No relevant relationships to disclose